Author: Cindi, Zinhle Andile
Author: Mateza, Somila
Similar Items: Pharmacogenetics of Tenofovir (Alafenamide or Disoproxil Fumarate Prodrug) Renal Toxicity in HIV positive Black Southern Africans
- Efavirenz pharmacogenetics and metabolic toxicity in black South Africans
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
- Investigating a semi-continuous synthetic pathway for the preparation of the antiretroviral drugs tenofovir disoproxil and tenofovir alafenamide
- Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
- Longitudinal Evaluation of Liver and Renal Functions in Patients Undergoing Tenofovir Disoproxil Fumarate–Based Antiretroviral Therapy in Southern Vietnam
Similar Items: Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
- Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
- Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
- Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Pharmacogenetics of Tenofovir (Alafenamide or Disoproxil Fumarate Prodrug) Renal Toxicity in HIV positive Black Southern Africans
- Effect of dihydroartemisin-piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV